Richard Buchholz - 01 Apr 2022 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Financial Officer
Signature
/s/ Bryan Phillips as Attorney-in-Fact for Richard Buchholz
Issuer symbol
INSP
Transactions as of
01 Apr 2022
Net transactions value
-$3,880,104
Form type
4
Filing time
05 Apr 2022, 19:41:45 UTC
Previous filing
15 Feb 2022
Next filing
13 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Gift $0 -250 -0.4% $0.000000 62,426 17 Feb 2022 Direct F1
transaction INSP Common Stock Gift $0 +125 +12% $0.000000 1,125 17 Feb 2022 By Daughter
transaction INSP Common Stock Gift $0 +125 +12% $0.000000 1,125 17 Feb 2022 By Son
transaction INSP Common Stock Gift $0 -250 -0.4% $0.000000 62,176 18 Feb 2022 Direct
transaction INSP Common Stock Gift $0 +125 +12% $0.000000 1,125 18 Feb 2022 By Son
transaction INSP Common Stock Gift $0 +125 +12% $0.000000 1,125 18 Feb 2022 By Son
transaction INSP Common Stock Sale $1,427,030 -5,500 -8.8% $259.46 56,676 01 Apr 2022 Direct F2, F3
transaction INSP Common Stock Sale $1,386,077 -5,362 -9.5% $258.50 51,314 01 Apr 2022 Direct F2, F4
transaction INSP Common Stock Sale $1,041,142 -4,037 -7.9% $257.90 47,277 01 Apr 2022 Direct F2, F5
transaction INSP Common Stock Sale $25,855 -101 -0.21% $255.99 47,176 01 Apr 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 52 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan on December 31, 2021.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.10 to $259.675. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.04 to $259.01. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.04 to $258.03. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.